GSK Challenge: Innovative Ways to Inform Healthcare Professionals

ABSTRACT

GSK, one of the world’s leading science-led pharmaceutical and healthcare companies, is seeking partners with innovative new technologies, platforms, or ways of working to engage healthcare professionals and help keep them informed about GSK’s science, clinical pathways, and provide them with accurate information about disease areas specific to vaccines. GSK is targeting partners with ready-to-go methods, platforms, channels, and/or technologies, and insights on how to apply those to the world of healthcare professionals, specifically working in vaccines.

This is an electronic Request-for-Partners (eRFP) Challenge; the Solver will only need to submit a written proposal to be evaluated by the Seeker with the goal of establishing a collaborative partnership.

OVERVIEW

An important challenge for GSK Vaccines is to keep healthcare professionals (HCPs) informed about the latest science on topics such as disease awareness, immunizations, and vaccine development and best practices. Traditional routes to accomplish this include in-person visits by sales and medical representatives with HCPs and the use of digital channels such as webinars, websites and emails. Even before the current pandemic curtailed office visits by representatives, it was difficult to reach and inform every HCP, a situation that has only become more challenging in the absence of face-to-face meetings. There are a variety of reasons some HCPs are difficult to reach. Some may suffer from information overload and although they receive the information, they don’t engage. Others may not receive the information due to their geographic location or because their specialty is considered out of scope as primary vaccinators. GSK is seeking to partner with companies that have innovative new ways to reach HCPs to keep them informed about GSK’s science and provide them with accurate medical information about vaccines.

This is an electronic Request-for-Partners (eRFP) Challenge. The Solver will write a preliminary proposal (about 2-4 pages, including supporting non-confidential information and contact details) to be evaluated by the Seeker with a goal of establishing a collaborative partnership. Upon completion of the evaluation, the Seeker may contact selected Solvers directly to work out terms for a collaboration contract. The monetary value of the contract will vary depending on the amount of work to be delivered and the agreed upon time frame.

NOTE: Only proposals from Solvers who have the ability to work as the collaboration partner will be considered.

Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on 26-May-2021.
Late submissions will not be considered.

ABOUT THE SEEKER

As one of the world’s leading science-led pharmaceutical and healthcare companies, GSK is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. For further information, please visit http://www.gsk.com.

What is InnoCentive?

InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is an eRFP Challenge?

An InnoCentive eRFP Challenge allows Seekers to submit Requests for Proposals for a partner or supplier to provide materials or expertise to solve a business challenge by leveraging the InnoCentive Solver network. This global community includes organizations and individuals, such as contract research organizations, scientists, university researchers, and technology companies.

After a Solver submits an eRFP response, the Seeker evaluates the responses to determine which Solver(s) to contact for further business discussions. With eRFPs, the Solver must not provide any confidential information in the eRFP response. If your eRFP response is selected, you negotiate the terms of the contract (including scope of work, tasks and duration) directly with the Seeker.

This Challenge type does not require Intellectual Property (IP) transfer. However, sometimes Seekers request that certain IP arrangements be made should a partnership be formed.